0001654954-21-008084.txt : 20210720 0001654954-21-008084.hdr.sgml : 20210720 20210720170050 ACCESSION NUMBER: 0001654954-21-008084 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210720 DATE AS OF CHANGE: 20210720 EFFECTIVENESS DATE: 20210720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENAX THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000034956 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262593535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-407038 FILM NUMBER: 211101791 BUSINESS ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-806-4414 MAIL ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: OXYGEN BIOTHERAPEUTICS, INC. DATE OF NAME CHANGE: 20080703 FORMER COMPANY: FORMER CONFORMED NAME: SYNTHETIC BLOOD INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SINEQUANON CORP DATE OF NAME CHANGE: 19901219 D 1 primary_doc.xml X0708 D LIVE 0000034956 TENAX THERAPEUTICS, INC. ONE COPLEY PARKWAY ONE COPLEY PARKWAY MORRISVILLE NC NORTH CAROLINA 27560 (919) 855-2100 DELAWARE OXYGEN BIOTHERAPEUTICS, INC. SYNTHETIC BLOOD INTERNATIONAL INC SINEQUANON CORP Corporation true Michael Jebsen One Copley Parkway Suite 490 Morrisville NC NORTH CAROLINA 27560 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2021-07-08 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue 3rd Floor New York NY NEW YORK 10022 AK ALASKA AL ALABAMA AR ARKANSAS AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA DE DELAWARE FL FLORIDA GA GEORGIA HI HAWAII IA IOWA ID IDAHO IL ILLINOIS IN INDIANA KS KANSAS KY KENTUCKY LA LOUISIANA MA MASSACHUSETTS MD MARYLAND ME MAINE MI MICHIGAN MN MINNESOTA MO MISSOURI MS MISSISSIPPI MT MONTANA NC NORTH CAROLINA ND NORTH DAKOTA NE NEBRASKA NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO NV NEVADA NY NEW YORK OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA PR PUERTO RICO RI RHODE ISLAND SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA VT VERMONT WA WASHINGTON WI WISCONSIN WV WEST VIRGINIA WY WYOMING 9999998 9999998 0 The amount sold reflects the purchase amount of the warrants issued to the Investor. false 1 750000 true 0 H.C. Wainwright & Co., LLC, a prior placement agent, received a tail fee of approximately $750,000 and a warrant for 357,995 shares of common stock exercisable at $2.46 per share. 0 A portion of the proceeds may be used for general corporate purposes, including to pay salaries of some related persons listed in Item 3. Tenax Therapeutics, Inc. /s/ Nancy J.M. Hecox Nancy J.M. Hecox Corporate Secretary 2021-07-20